financetom
Business
financetom
/
Business
/
Ares Management Insider Sold Shares Worth $5,204,475, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ares Management Insider Sold Shares Worth $5,204,475, According to a Recent SEC Filing
Mar 20, 2024 3:01 AM

05:38 AM EDT, 03/20/2024 (MT Newswires) -- Michael J Arougheti, Director, Co-Founder, CEO and President, around March 18, 2024, sold 39,664 shares in Ares Management ( ARES ) for $5,204,475. Following the Form 4 filing with the SEC, Arougheti has control over a total of 1,471,144 shares of the company, with 1,375,000 shares held directly and 96,144 shares controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1176948/000162828024012048/xslF345X03/wk-form4_1710899341.xml

Price: 132.79, Change: +0.62, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Option Care Health's Q4 Adjusted Earnings, Net Revenue Rise; 2025 Guidance Issued
Option Care Health's Q4 Adjusted Earnings, Net Revenue Rise; 2025 Guidance Issued
Feb 26, 2025
07:32 AM EST, 02/26/2025 (MT Newswires) -- Option Care Health ( OPCH ) reported Q4 adjusted earnings Wednesday of $0.44 per diluted share, compared with $0.38 a year earlier. Analysts surveyed by FactSet expected $0.36. Net revenue for the quarter ended Dec. 31 was $1.35 billion, compared with $1.12 billion a year earlier. Analysts surveyed by FactSet expected $1.29 billion....
NRG Energy's Q4 Adjusted Earnings, Revenue Rise; 2025 Non-GAAP EPS Guidance Set
NRG Energy's Q4 Adjusted Earnings, Revenue Rise; 2025 Non-GAAP EPS Guidance Set
Feb 26, 2025
07:32 AM EST, 02/26/2025 (MT Newswires) -- NRG Energy ( NRG ) reported Q4 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.11 a year earlier. An analyst polled by FactSet expected $1.27. Revenue for the quarter ended Dec. 31 was $6.86 billion, compared with $6.77 billion a year earlier. The analyst surveyed by FactSet expected $7.82 billion....
Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases
Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases
Feb 26, 2025
07:31 AM EST, 02/26/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) reported Wednesday its Q4 loss widened to $0.72 per diluted share from $0.70 per share a year earlier. Analysts polled by FactSet expected a loss of $0.69 per share. Revenue for the quarter ended Dec. 31 was $41.8 million, up from $24.2 million a year earlier. Analysts surveyed...
Ukraine outlines U.S. minerals deal, but touts no concrete security guarantees
Ukraine outlines U.S. minerals deal, but touts no concrete security guarantees
Feb 26, 2025
KYIV (Reuters) - Ukraine's prime minister disclosed the details of a draft minerals deal with the United States on Wednesday, saying its wording showed Washington backed Kyiv's effort to get security guarantees, but touting nothing more concrete for now. The deal is at the heart of Kyiv's push to win over Donald Trump's robust support as the U.S. president strives...
Copyright 2023-2026 - www.financetom.com All Rights Reserved